Drug-Related Side Effects and Adverse Reactions

Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.
Also Known As:
Adverse Drug Event; Adverse Drug Reaction; Drug Side Effects; Drug Toxicity; Side Effects of Drugs; Toxicity, Drug; Adverse Drug Events; Adverse Drug Reactions; Drug Event, Adverse; Drug Events, Adverse; Drug Reaction, Adverse; Drug Reactions, Adverse; Drug Related Side Effects and Adverse Reaction; Drug Related Side Effects and Adverse Reactions; Drug Side Effect; Drug Toxicities; Effects, Drug Side; Reactions, Adverse Drug; Side Effect, Drug; Side Effects, Drug; Toxicities, Drug; Drug-Related Side Effects and Adverse Reaction
Networked: 14051 relevant articles (552 outcomes, 1481 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Infections
3. HIV Infections (HIV Infection)
4. Nausea
5. Vomiting


1. Montastruc, Jean-Louis: 56 articles (01/2023 - 01/2003)
2. Bates, David W: 44 articles (12/2023 - 07/2002)
3. Pirmohamed, Munir: 28 articles (01/2023 - 10/2003)
4. Uchida, Mayako: 27 articles (04/2024 - 11/2004)
5. Lapeyre-Mestre, Maryse: 27 articles (07/2023 - 05/2003)
6. de Leon, Jose: 25 articles (04/2024 - 08/2003)
7. Montastruc, François: 25 articles (04/2024 - 01/2013)
8. Bagheri, Haleh: 25 articles (02/2024 - 01/2003)
9. Sukasem, Chonlaphat: 24 articles (04/2024 - 01/2014)
10. O'Mahony, Denis: 24 articles (12/2023 - 01/2008)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Drug-Related Side Effects and Adverse Reactions:
1. Biomarkers (Surrogate Marker)IBA
2. Anti-Bacterial Agents (Antibiotics)IBA
3. EnzymesIBA
4. Therapeutic UsesIBA
5. Adrenal Cortex Hormones (Corticosteroids)IBA
6. Liposomes (Liposome)IBA
7. Antiviral Agents (Antivirals)IBA
8. SteroidsIBA
9. Antipsychotic Agents (Antipsychotics)IBA
10. 2-mercaptopurineIBA

Therapies and Procedures

1. Therapeutics
02/01/2020 - "The most anticipated outcomes were improved the effectiveness of therapy (45.1%, n = 1909), avoid adverse drug reactions (29%, n = 1228), and decrease the cost of medications (18.8%, n = 797). "
01/01/2020 - "Thus, we describe here some of the challenges identified with treating AML including off-target toxicity, drug transporters, clonal heterogeneity, and adaptive resistance, and some of the most promising opportunities for improved therapy."
01/01/2014 - "Although antiretroviral (ARV) therapy has dramatically improved the quality of life and increased the life expectancy of those infected with HIV but frequency of dosing and drug toxicity as well as the development of viral resistance pose additional limitations. "
11/01/2001 - "Some of these important developments are the delineation of mechanisms of nonsteroidal anti-inflammatory drug-induced gastrointestinal toxicity, identification of groups at highest risk for development of nonsteroidal anti-inflammatory drug-induced gastrointestinal complications, recognition of co-therapies that could reduce nonsteroidal anti-inflammatory drug toxicity, and, most recently, development of classes of nonsteroidal anti-inflammatory drugs with improved gastrointestinal safety profiles. "
11/01/2021 - "Medical imaging is becoming increasingly important in the evaluation of kidney physiology and pathophysiology, showing promise in management of patients with renal disease, in particular with regard to diagnosis, classification, and prediction of disease development and progression, monitoring response to therapy, detection of drug toxicity, and patient selection for clinical trials. "
2. Drug Therapy (Chemotherapy)
3. Polypharmacy
4. Medication Errors (Medication Error)
5. Drug Prescriptions